vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.

Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $11.9M, roughly 1.6× ASCENT INDUSTRIES CO.). Electromed, Inc. runs the higher net margin — 14.6% vs -8.8%, a 23.4% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 13.3%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $-196.0K). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -34.9%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.

ACNT vs ELMD — Head-to-Head

Bigger by revenue
ELMD
ELMD
1.6× larger
ELMD
$18.9M
$11.9M
ACNT
Growing faster (revenue YoY)
ELMD
ELMD
+2.9% gap
ELMD
16.3%
13.3%
ACNT
Higher net margin
ELMD
ELMD
23.4% more per $
ELMD
14.6%
-8.8%
ACNT
More free cash flow
ELMD
ELMD
$2.6M more FCF
ELMD
$2.4M
$-196.0K
ACNT
Faster 2-yr revenue CAGR
ELMD
ELMD
Annualised
ELMD
16.7%
-34.9%
ACNT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ACNT
ACNT
ELMD
ELMD
Revenue
$11.9M
$18.9M
Net Profit
$-1.0M
$2.8M
Gross Margin
14.6%
78.4%
Operating Margin
-21.0%
19.2%
Net Margin
-8.8%
14.6%
Revenue YoY
13.3%
16.3%
Net Profit YoY
-1.2%
40.3%
EPS (diluted)
$-0.11
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
ELMD
ELMD
Q4 25
$11.9M
$18.9M
Q3 25
$19.7M
$16.9M
Q2 25
$18.7M
$17.4M
Q1 25
$24.7M
$15.7M
Q4 24
$10.5M
$16.3M
Q3 24
$20.9M
$14.7M
Q2 24
$21.5M
$14.8M
Q1 24
$28.0M
$13.9M
Net Profit
ACNT
ACNT
ELMD
ELMD
Q4 25
$-1.0M
$2.8M
Q3 25
$-2.1M
$2.1M
Q2 25
$6.3M
$2.2M
Q1 25
$-2.3M
$1.9M
Q4 24
$-1.0M
$2.0M
Q3 24
$-6.2M
$1.5M
Q2 24
$-926.0K
$1.8M
Q1 24
$-5.5M
$1.5M
Gross Margin
ACNT
ACNT
ELMD
ELMD
Q4 25
14.6%
78.4%
Q3 25
29.7%
78.1%
Q2 25
26.1%
78.3%
Q1 25
19.3%
78.0%
Q4 24
24.3%
77.7%
Q3 24
14.4%
78.3%
Q2 24
13.1%
76.2%
Q1 24
8.3%
74.8%
Operating Margin
ACNT
ACNT
ELMD
ELMD
Q4 25
-21.0%
19.2%
Q3 25
-4.1%
15.8%
Q2 25
-14.4%
17.5%
Q1 25
-4.2%
13.6%
Q4 24
-25.4%
15.6%
Q3 24
-9.4%
13.2%
Q2 24
-8.6%
15.7%
Q1 24
-15.5%
13.3%
Net Margin
ACNT
ACNT
ELMD
ELMD
Q4 25
-8.8%
14.6%
Q3 25
-10.6%
12.6%
Q2 25
33.7%
12.7%
Q1 25
-9.3%
12.1%
Q4 24
-9.8%
12.1%
Q3 24
-29.5%
10.0%
Q2 24
-4.3%
12.3%
Q1 24
-19.7%
10.8%
EPS (diluted)
ACNT
ACNT
ELMD
ELMD
Q4 25
$-0.11
$0.32
Q3 25
$-0.22
$0.25
Q2 25
$0.65
$0.26
Q1 25
$-0.23
$0.21
Q4 24
$-0.11
$0.22
Q3 24
$-0.61
$0.16
Q2 24
$-0.09
$0.20
Q1 24
$-0.54
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
ELMD
ELMD
Cash + ST InvestmentsLiquidity on hand
$57.6M
$13.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$45.4M
Total Assets
$111.9M
$54.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
ELMD
ELMD
Q4 25
$57.6M
$13.8M
Q3 25
$58.0M
$14.1M
Q2 25
$60.5M
$15.3M
Q1 25
$14.3M
$15.2M
Q4 24
$16.1M
$16.2M
Q3 24
$8.5M
$13.9M
Q2 24
$3.6M
$16.1M
Q1 24
$1.3M
$11.7M
Total Debt
ACNT
ACNT
ELMD
ELMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
ELMD
ELMD
Q4 25
$87.0M
$45.4M
Q3 25
$87.1M
$44.7M
Q2 25
$89.7M
$43.2M
Q1 25
$91.2M
$43.9M
Q4 24
$93.5M
$43.6M
Q3 24
$94.7M
$41.5M
Q2 24
$101.0M
$44.5M
Q1 24
$102.0M
$42.5M
Total Assets
ACNT
ACNT
ELMD
ELMD
Q4 25
$111.9M
$54.9M
Q3 25
$119.9M
$53.6M
Q2 25
$122.6M
$53.8M
Q1 25
$152.5M
$52.5M
Q4 24
$147.3M
$52.3M
Q3 24
$148.6M
$48.9M
Q2 24
$158.2M
$52.2M
Q1 24
$161.0M
$48.9M
Debt / Equity
ACNT
ACNT
ELMD
ELMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
ELMD
ELMD
Operating Cash FlowLast quarter
$266.0K
$3.0M
Free Cash FlowOCF − Capex
$-196.0K
$2.4M
FCF MarginFCF / Revenue
-1.7%
12.7%
Capex IntensityCapex / Revenue
3.9%
3.4%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$-2.1M
$7.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
ELMD
ELMD
Q4 25
$266.0K
$3.0M
Q3 25
$1.3M
$169.0K
Q2 25
$-1.4M
$3.9M
Q1 25
$-700.0K
$2.1M
Q4 24
$8.8M
$3.2M
Q3 24
$3.4M
$2.3M
Q2 24
$2.2M
$4.5M
Q1 24
$263.0K
$1.4M
Free Cash Flow
ACNT
ACNT
ELMD
ELMD
Q4 25
$-196.0K
$2.4M
Q3 25
$695.0K
$-83.0K
Q2 25
$-1.5M
$3.7M
Q1 25
$-1.0M
$1.9M
Q4 24
$8.4M
$2.9M
Q3 24
$3.1M
$2.3M
Q2 24
$1.9M
$4.5M
Q1 24
$25.0K
$1.3M
FCF Margin
ACNT
ACNT
ELMD
ELMD
Q4 25
-1.7%
12.7%
Q3 25
3.5%
-0.5%
Q2 25
-8.3%
21.4%
Q1 25
-4.1%
12.2%
Q4 24
80.6%
18.0%
Q3 24
15.1%
15.5%
Q2 24
9.1%
30.1%
Q1 24
0.1%
9.1%
Capex Intensity
ACNT
ACNT
ELMD
ELMD
Q4 25
3.9%
3.4%
Q3 25
3.1%
1.5%
Q2 25
0.8%
0.8%
Q1 25
1.3%
1.0%
Q4 24
3.7%
1.4%
Q3 24
1.3%
0.3%
Q2 24
1.0%
0.1%
Q1 24
0.9%
0.6%
Cash Conversion
ACNT
ACNT
ELMD
ELMD
Q4 25
1.10×
Q3 25
0.08×
Q2 25
-0.22×
1.75×
Q1 25
1.10×
Q4 24
1.60×
Q3 24
1.57×
Q2 24
2.46×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

ELMD
ELMD

Homecare$17.3M91%
Other$1.6M9%

Related Comparisons